ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in San Francisco, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections
Infections
Post-Acute COVID-19 Syndrome
Pneumonia
Virus Diseases
Human Influenza
Respiratory Tract Infections

COVID-19 trials near San Francisco, CA, USA:

Imaging Immune Activation in COVID-19

by whole-body PET-CT imaging in participants with convalescent COVID-19. Up to 80 participants will be enrolled over an accrual per...

Enrolling
Covid19
SARS-CoV Infection
Drug: [18F]F-AraG (2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguanine)

Phase 2

CellSight Technologies

San Francisco, California, United States

This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19...

Active, not recruiting
COVID-19
Sars-CoV-2 Infection
Biological: NVX-CoV2705
Biological: Placebo

Phase 4

Novavax
Novavax

Walnut Creek, Colorado, United States of America and 98 other locations

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...

Enrolling
Coronavirus Disease (COVID-19)
Drug: Placebo
Drug: Molnupiravir

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

San Francisco, California, United States and 227 other locations

The purpose of this study is to learn about the safety and effects of an updated COVID-19 vaccine (called BNT162b2) in adults 18 to-...

Enrolling
COVID-19 Vaccines
Biological: BNT162b2 Vaccine
Biological: Tdap Vaccine

Phase 4

BioNTech
BioNTech

Walnut Creek, California, United States and 4 other locations

There is a pressing need to increase capacity to treat PTSD related to or exacerbated by the COVID-19 pandemic. Texting-based thera...

Active, not recruiting
Posttraumatic Stress Disorder
Behavioral: Reminder as Usual
Behavioral: CPT-Text
Stanford University
Stanford University

Palo Alto, California, United States and 2 other locations

This study will test the safety and tolerability of Anktiva in patients with Long Covid. Eligible patients will receive up to 2 doses of Anktiva and...

Enrolling
Long COVID
Drug: N-803 (IL-15 Superagonist)

Phase 2

ImmunityBio
ImmunityBio

San Francisco, California, United States

Persistent viral infection with viral reservoirs and detection of circulating spike protein after the initial acute illness is one potential pathogen...

Active, not recruiting
Post-Acute COVID-19
Post Acute Sequelae of COVID-19
Drug: Ensitrelvir
Other: Placebo

Phase 2

Timothy Henrich

San Francisco, California, United States

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting
Early Alzheimer's Disease
Drug: Lecanemab SC
Drug: Placebo

Phase 3

Eisai
Eisai

San Francisco, California, United States of America and 249 other locations

treatment in Study M16-067 with no final endoscopy due to the Covid-19 pandemic or due to the geopolitical conflict in Ukraine and ...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: placebo for risankizumab
Drug: risankizumab

Phase 3

AbbVie
AbbVie

San Francisco, California, United States and 436 other locations

in Study M16-006 or Study M15-991 with no final endoscopy due to the Covid-19 pandemic. Additional objectives are to further invest...

Active, not recruiting
Crohn's Disease
Drug: Placebo for Risankizumab IV
Drug: Risankizumab SC

Phase 3

AbbVie
AbbVie

San Francisco, California, United States and 507 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems